309 related articles for article (PubMed ID: 25604979)
1. The benefit of PET/CT in the diagnosis and treatment of esophageal cancer.
Vomackova K; Neoral C; Aujeský R; Vrba R; Stasek M; Myslivecek M; Formánek R
Rozhl Chir; 2015 Jan; 94(1):8-16. PubMed ID: 25604979
[TBL] [Abstract][Full Text] [Related]
2. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
Bruzzi JF; Swisher SG; Truong MT; Munden RF; Hofstetter WL; Macapinlac HA; Correa AM; Mawlawi O; Ajani JA; Komaki RR; Fukami N; Erasmus JJ
Cancer; 2007 Jan; 109(1):125-34. PubMed ID: 17146785
[TBL] [Abstract][Full Text] [Related]
3. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
[TBL] [Abstract][Full Text] [Related]
4. Multimodal imaging of esophagus and cardia cancer before and after treatment.
Fiore D; Baggio V; Ruol A; Bocus P; Casara D; Corti L; Muzzio PC
Radiol Med; 2006 Sep; 111(6):804-17. PubMed ID: 16896560
[TBL] [Abstract][Full Text] [Related]
5. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Kukar M; Alnaji RM; Jabi F; Platz TA; Attwood K; Nava H; Ben-David K; Mattson D; Salerno K; Malhotra U; Kanehira K; Gannon J; Hochwald SN
JAMA Surg; 2015 Jun; 150(6):555-62. PubMed ID: 25902198
[TBL] [Abstract][Full Text] [Related]
6. Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.
Piessen G; Petyt G; Duhamel A; Mirabel X; Huglo D; Mariette C
Ann Surg; 2013 Jul; 258(1):66-76. PubMed ID: 23470576
[TBL] [Abstract][Full Text] [Related]
7. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
8. The value of ¹⁸F-FDG PET/CT in assessment of metabolic response in esophageal cancer for prediction of histopathological response and survival after preoperative chemoradiotherapy.
Myslivecek M; Neoral C; Vrba R; Vomackova K; Cincibuch J; Formanek R; Koranda P; Zapletalova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):171-9. PubMed ID: 22660205
[TBL] [Abstract][Full Text] [Related]
9. The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma.
Blom RL; Schreurs WM; Belgers HJ; Oostenbrug LE; Vliegen RF; Sosef MN
Eur J Surg Oncol; 2011 Sep; 37(9):774-8. PubMed ID: 21726976
[TBL] [Abstract][Full Text] [Related]
10. Palliative esophagectomy in unexpected metastatic disease: sense or nonsense?
Depypere LP; Moons J; Lerut TE; Coosemans W; Van Veer H; Nafteux PR
Asian Cardiovasc Thorac Ann; 2018 Sep; 26(7):552-557. PubMed ID: 30185072
[TBL] [Abstract][Full Text] [Related]
11. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiation for esophageal cancer : Surgery improves locoregional control while response based on FDG-PET/CT predicts survival.
Hegemann NS; Koepple R; Walter F; Boeckle D; Fendler WP; Angele MK; Boeck S; Belka C; Roeder F
Strahlenther Onkol; 2018 May; 194(5):435-443. PubMed ID: 29349603
[TBL] [Abstract][Full Text] [Related]
13. Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer.
Hocazade C; Özdemir N; Yazici O; Bozkaya Y; Yazılıtaş D; Toptaş Ş; Zengin N; Deren T
Ann Nucl Med; 2015 Aug; 29(7):621-6. PubMed ID: 26008856
[TBL] [Abstract][Full Text] [Related]
14. Treatment results of neoadjuvant chemoradiotherapy followed by radical esophagectomy in patients with initially inoperable thoracic esophageal cancer.
Morimoto H; Fujiwara Y; Lee S; Amano K; Hosono M; Miki Y; Osugi H
Jpn J Radiol; 2018 Jan; 36(1):23-29. PubMed ID: 29080946
[TBL] [Abstract][Full Text] [Related]
15. Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer.
Stiekema J; Vermeulen D; Vegt E; Voncken FE; Aleman BM; Sanders J; Boot H; van Sandick JW
Clin Nucl Med; 2014 Oct; 39(10):862-7. PubMed ID: 25140549
[TBL] [Abstract][Full Text] [Related]
16.
Xi M; Liao Z; Hofstetter WL; Komaki R; Ho L; Lin SH
J Nucl Med; 2017 Nov; 58(11):1756-1763. PubMed ID: 28522744
[TBL] [Abstract][Full Text] [Related]
17. Esophageal cancer: the role of integrated CT-PET in initial staging and response assessment after preoperative therapy.
Munden RF; Macapinlac HA; Erasmus JJ
J Thorac Imaging; 2006 May; 21(2):137-45. PubMed ID: 16770230
[TBL] [Abstract][Full Text] [Related]
18. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose PET/computed tomography and risk stratification after neoadjuvant treatment in esophageal cancer patients.
Cervino AR; Pomerri F; Alfieri R; Sileni VC; Castoro C; Galuppo S; Evangelista L
Nucl Med Commun; 2014 Feb; 35(2):160-8. PubMed ID: 24220054
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma.
Yasuda T; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Doki Y
Ann Surg Oncol; 2015 Aug; 22(8):2599-607. PubMed ID: 25524011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
